Author:
den Ouden Henk,Pellis Linette,Rutten Guy E. H. M.,Geerars-van Vonderen Ilse K.,Rubingh Carina M.,van Ommen Ben,van Erk Marjan J.,Beulens Joline W. J.
Funder
novo nordisk netherlands
GlaxoSmithKline Netherlands
Merck Netherlands
Ely Lilly Netherlands
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference46 articles.
1. Aquilante, C. L. (2010). Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms. Expert Review of Cardiovascular Therapy, 3, 359–372.
2. Bain, J. R., Stevens, R. D., Wenner, B. R., et al. (2009). Metabolomics applied to diabetes research: Moving from information to knowledge. Diabetes, 58, 2429–2443.
3. Bao, Y., Zhao, T., Wang, X., et al. (2009). Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. Journal of Proteome Research, 8, 1623–1630.
4. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57, 289–300.
5. Bertolo, R. F., & Burrin, D. G. (2008). Comparative aspects of tissue glutamine and proline metabolism. Journal of Nutrition, 138, 2032–2039.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献